WS
Winifred L Swan
SVP and General Counsel

Winifred L Swan insider trades: NxStage Medical (NXTM) stock sales

SVP and General Counsel, NxStage Medical Last trade Feb 20, 2018 119 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
97
Open-market trades
since 2010
1
Company
last trade 2018

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Winifred reports to the SEC

Open-market buys and sales

97 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 20, 2018NXTM↓ Sell$86K
Jan 16, 2018NXTM↓ Sell$87K
Dec 20, 2017NXTM↓ Sell$89K
Nov 15, 2017NXTM↓ Sell$90K
Oct 20, 2017NXTM↓ Sell$96K
Sep 20, 2017NXTM↓ Sell$95K
Aug 15, 2017NXTM↓ Sell$102K
Jul 20, 2017NXTM↓ Sell$85K
Jun 15, 2017NXTM↓ Sell$81K
May 15, 2017NXTM↓ Sell$77K
Apr 20, 2017NXTM↓ Sell$95K
Mar 20, 2017NXTM↓ Sell$435K
Feb 15, 2017NXTM↓ Sell$450K
Jan 20, 2017NXTM↓ Sell$92K
Dec 15, 2016NXTM↓ Sell$91K
Nov 22, 2016NXTM↓ Sell$77K
Apr 14, 2016NXTM↓ Sell$103K
Mar 14, 2016NXTM↓ Sell$10K
Feb 16, 2016NXTM↓ Sell$35K
Jan 14, 2016NXTM↓ Sell$12K
Dec 14, 2015NXTM↓ Sell$47K
Nov 16, 2015NXTM↓ Sell$49K
Oct 14, 2015NXTM↓ Sell$39K
Sep 14, 2015NXTM↓ Sell$40K
Aug 14, 2015NXTM↓ Sell$45K
Jul 14, 2015NXTM↓ Sell$37K
Jun 15, 2015NXTM↓ Sell$39K
May 18, 2015NXTM↓ Sell$42K
May 14, 2015NXTM↓ Sell$8K
Apr 15, 2015NXTM↓ Sell$9K
Mar 19, 2015NXTM↓ Sell$9K
Feb 18, 2015NXTM↓ Sell$9K
Jan 14, 2015NXTM↓ Sell$21K
Dec 29, 2014NXTM↓ Sell$12K
Dec 22, 2014NXTM↓ Sell$12K
Dec 18, 2014NXTM↓ Sell$9K
Dec 1, 2014NXTM↓ Sell$284K
Nov 14, 2014NXTM↓ Sell$298K
Nov 7, 2014NXTM↓ Sell$271K
Nov 5, 2014NXTM↓ Sell$184K
Oct 15, 2014NXTM↓ Sell$45K
Aug 15, 2014NXTM↓ Sell$34K
Jul 18, 2014NXTM↓ Sell$27K
Jul 17, 2014NXTM↓ Sell$7K
Jun 9, 2014NXTM↓ Sell$129K
Jun 5, 2014NXTM↓ Sell$105K
May 15, 2014NXTM↓ Sell$123K
May 14, 2014NXTM↓ Sell$65K
Sep 17, 2012NXTM↓ Sell$39K
Aug 14, 2012NXTM↓ Sell$41K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Winifred L Swan's insider trades

Winifred L Swan is SVP and General Counsel at NxStage Medical (NXTM). Since Mar 1, 2010, Winifred has reported no open-market purchases and 97 sales worth $10.7M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (86 filings), grants and awards (17 filings), shares withheld for taxes (13 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NXTM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.